Search

Your search keyword '"Meyer, Michelle N."' showing total 7 results
Start Over Author "Meyer, Michelle N." Journal hastings center report
7 results on '"Meyer, Michelle N."'

3. Wrestling with Social and Behavioral Genomics: Risks, Potential Benefits, and Ethical Responsibility

Author

Meyer, Michelle N., primary, Appelbaum, Paul S., additional, Benjamin, Daniel J., additional, Callier, Shawneequa L., additional, Comfort, Nathaniel, additional, Conley, Dalton, additional, Freese, Jeremy, additional, Garrison, Nanibaa' A., additional, Hammonds, Evelynn M., additional, Harden, K. Paige, additional, Lee, Sandra Soo‐Jin, additional, Martin, Alicia R., additional, Martschenko, Daphne Oluwaseun, additional, Neale, Benjamin M., additional, Palmer, Rohan H. C., additional, Tabery, James, additional, Turkheimer, Eric, additional, Turley, Patrick, additional, and Parens, Erik, additional

Published
2023
Full Text
View/download PDF

4. Allocation of Opportunities to Participate in Clinical Trials during the Covid‐19 Pandemic and Other Public Health Emergencies

Author

Spector‐Bagdady, Kayte, primary, Lynch, Holly Fernandez, additional, Bierer, Barbara E., additional, Gelinas, Luke, additional, Hull, Sara Chandros, additional, Magnus, David, additional, Meyer, Michelle N., additional, Sharp, Richard R., additional, Sugarman, Jeremy, additional, Wilfond, Benjamin S., additional, Yearby, Ruqaiijah, additional, and Mohapatra, Seema, additional

Published
2021
Full Text
View/download PDF

5. Allocation of Opportunities to Participate in Clinical Trials during the Covid‐19 Pandemic and Other Public Health Emergencies.

Author

Spector‐Bagdady, Kayte, Lynch, Holly Fernandez, Bierer, Barbara E., Gelinas, Luke, Hull, Sara Chandros, Magnus, David, Meyer, Michelle N., Sharp, Richard R., Sugarman, Jeremy, Wilfond, Benjamin S., Yearby, Ruqaiijah, and Mohapatra, Seema

Subjects
THERAPEUTIC use of monoclonal antibodies, CLINICAL trials, PATIENT participation, COVID-19, PREVENTION of communicable diseases, PUBLIC health, MEDICAL emergencies, PATIENTS' attitudes, MEDICAL referrals, COVID-19 pandemic
Abstract

Covid‐19 raised many novel ethical issues including regarding the allocation of opportunities to participate in clinical trials during a public health emergency. In this article, we explore how hospitals that have a scarcity of trial opportunities, either overall or in a specific trial, can equitably allocate those opportunities in the context of an urgent medical need with limited therapeutic interventions. We assess the three main approaches to allocating trial opportunities discussed in the literature: patient choice, physician referral, and randomization/lottery. As, we argue, none of the three typical approaches are ethically ideal for allocating trial opportunities in the pandemic context, many hospitals have instead implemented hybrid solutions. We offer practical guidance to support those continuing to face these challenges, and we analyze options for the future. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results